Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Moby Intelligence

Tue, August 11, 2026 at 11:55 PM GMT+3 3 min read

AMBQ +0.46%

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary - Moby

Strategic Performance Drivers

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

Management attributes the 90% year-over-year revenue growth to a step change in Edge AI demand, with end-user consumption far exceeding initial customer expectations.
Performance was driven by double-digit growth in Apollo II and Apollo IV, while Apollo V sales more than doubled year-over-year, supported by the ramping of a new large customer.
Lean channel inventory and persistent expedite requests indicate that growth reflects underlying end-market consumption rather than inventory replenishment cycles.
The company is navigating significant supply constraints across wafers, packaging, substrates, and testing, which is currently limiting the ability to meet total customer demand.
Management is actively working to secure additional foundry allocations and OSAT capacity to improve supply flexibility and convert deferred demand into future revenue.
Strategic expansion into medical, industrial, and smart home markets is progressing, with revenue from these diverse applications expected to more than double in 2026.
Power efficiency is being redefined as a fundamental requirement rather than just an advantage as Edge AI workloads become more sophisticated and memory-intensive.

Outlook and Strategic Roadmap

Third quarter net sales are projected to grow approximately 100% year-over-year, with full-year 2026 revenue is expected to be approximately $135 million despite supply headwinds.
Management expects modest year-over-year gross margin improvement in 2026, an upgrade from prior expectations of flat margins, driven by favorable product mix and manufacturing efficiencies.
The Atomiq 110 and Apollo 340 products are targeted for customer sampling in early 2027, with a meaningful revenue ramp for Atomiq 110 planned for 2028.
Full-year operating expense is projected at approximately $85 million, including $7 million to $10 million in intellectual property purchases necessary for next-generation product development.
The company intends to use the $168 million in net proceeds from its June follow-on offering to fund working capital and accelerate product roadmaps to capture long-term Edge AI opportunities.

Operational Risks and Structural Factors

Supply chain constraints are characterized as an industry-wide headwind that is currently capping the company's second-half 2026 revenue potential.
Rising component costs and industry-wide inflationary pressures are being partially offset by yield improvements and test time efficiencies as products ramp to full-scale manufacturing.
China-based sales accounted for approximately 14% of total net sales, with management focusing specifically on high-value Edge AI functionality within that region.
Intellectual property licensing costs are identified as a recurring variable expense tied directly to the sequencing of new product developments on the roadmap.

Q&A Session Highlights

Quantifying the impact of supply constraints on 2026 revenue

Management declined to provide a specific dollar figure for lost opportunity but noted that customer demand is 'skyrocketing' with new orders coming in weekly.
One specific example cited involved a customer launch where pre-orders were 3x to 5x higher than expected, creating immediate demand that was physically impossible to meet.

One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.

Development progress and market interest for Atomiq products

Early development platforms are already in customer hands via FPGA, with interest spanning multiple diverse end markets.
The development team is currently managing parallel tracks for Atomiq 110 and Apollo 340 to meet the 2027 sampling timeline.

Drivers of gross margin strength despite rising costs

Margin expansion is being driven by pricing strategies that extract maximum value for Edge AI enablement and significant manufacturing cost reductions.
Yield and test time improvements are successfully muting the impact of broader industry cost pressures.

Growth trends in displayless wearable form factors

Management highlighted 'displayless trackers' like smart rings and health bands as a high-growth area, driven by the rise of cloud-based AI agents.
These devices are increasingly functioning as medical-grade monitors for biosignals, requiring the ultra-low power compute Ambiq provides.

Path to profitability and future capital allocation

The company remains in a 'growth model' phase, prioritizing R&D investment over immediate cash flow breakeven.
Management indicated that the strengthened balance sheet provides the cash resources to grow the existing pipeline and develop new business opportunities. or portfolio expansion beyond current product lines.